ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,671.60
0.56%
S&P ASX All Technology
3,016.60
0.01%
Brent Oil
83.115
-0.01%
US Dollar vs AUD
1.51194
-0.06%
Bitcoin
64,141.31
0.22%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Day One Biopharmaceuticals Inc (DAWN)

  7. Day One Biopharmaceuticals Inc (DAWN) News

DAWN Day One Biopharmaceuticals Inc

17.25
-0.32 (-1.82%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Day One Biopharmaceuticals Inc DAWN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.32 -1.82% 17.25 14:00:06
Open Price Low Price High Price Close Price Previous Close
18.00 17.13 18.00 17.17 17.57
more quote information »

Recent News

Date Time Source Heading
08/3/202408:19EDGAR2Form 8-K - Current report
29/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:27EDGAR2Form 144 - Report of proposed sale of securities
21/2/202410:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202409:51EDGAR2Form 144 - Report of proposed sale of securities
18/1/202400:25EDGAR2Form 8-K - Current report
10/1/202411:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:30EDGAR2Form 8-K - Current report
05/1/202408:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/11/202310:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202310:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:07EDGAR2Form 8-K - Current report
17/11/202310:24EDGAR2Form 144 - Report of proposed sale of securities
16/11/202308:07EDGAR2Form 8-K - Current report
07/11/202308:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:30EDGAR2Form 8-K - Current report
31/10/202301:54DJNDay One Biopharmaceuticals Shares Rally on FDA Priority..
30/10/202323:58DJNDay One Gets FDA Priority Review of Tovorafenib in Pediatric..
30/10/202323:12EDGAR2Form 8-K - Current report
21/10/202307:01EDGAR2Form SC 13D/A - General statement of acquisition of..
15/9/202307:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/9/202322:35EDGAR2Form 8-K - Current report
18/8/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202322:06EDGAR2Form 8-K - Current report
08/8/202306:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:30EDGAR2Form 8-K - Current report
06/7/202309:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202321:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..

Your Recent History

NASDAQ
DAWN
Day One Biopharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved